华新水泥通过其子公司海南华新泛非投资有限公司和华新（香港）国际控股有限公司，与Holderfin B.V达成了一项价值8.3813亿美元的协议，收购Caricement B.V.和Davis Peak Holdings ...

器械之家医疗器械媒体报道先锋分享专业医疗器械知识关注 来源：器械之家，未经授权不得转载，且24小时后方可转载12月2日，GE医疗宣布将从住友化学收购日本领先放射性药物公司Nihon ...

12月1日，GE医疗宣布已与住友达成协议，将从住友化学手中收购其持有的Nihon Medi+Physics（NMP）50%股权，实现对日本核医学株式会社Nihon ...

GE HealthCare will acquire the remaining 50% stake in Nihon Medi-Physics, enabling it to fully own the Japanese ...

GE Healthcare has identified radiopharmaceuticals as a growth driver for the company and Japan as a key market.

智通财经获悉，GE HealthCare (GEHC.US)已同意从Sumitomo Chemical手中收购Nihon Medi-Physics (NMP)剩余50%的股份，旨在获得这家日本放射性制药公司的完全所有权。该公司预计该交易将于2025年初完成。该交易预计将对GE HealthCare第一年的调整后每股收益产生中性影响，此后将增加收益。

GE HealthCare has owned half of Nihon Medi-Physics since 2004, when former parent company General Electric obtained the stake ...

智通财经获悉，GE HealthCare (GEHC.US)已同意从Sumitomo Chemical手中收购Nihon Medi-Physics (NMP)剩余50%的股份，旨在获得这家日本放射性制药公司的完全所有权。该公司预计该交易将于2025年初完成。该交易预计将对GE HealthCare第一年的调整后每股收益产生中性影响，此后将增加收益。

NMP's product range includes GE HealthCare radiopharmaceuticals, which are essential for imaging in cardiology, oncology, and ...

GE Healthcare to fully acquire Nihon Medi-Physics from Sumitomo Chemical, enhancing its radiopharmaceutical and molecular ...

GE HealthCare to acquire remaining 50% stake in Nihon Medi-Physics (NMP), a leading radiopharmaceutical company in Japan, ...

GE Healthcare will acquire Nihon Medi-Physics (NMP), a Tokyo-based radiopharmaceutical firm, by buying the remaining 50% stake from parent Sumitomo Chemical, the companies said on Monday.